Background: The aim of the present study was to evaluate early results of thoracic endovascular aortic repair (TEVAR) using the Valiant NavionTM stent graft in a “real-world” scenario. Methods: All patients who underwent TEVAR with the Valiant NavionTM endograft between November 2018 and November 2019 were included in this retrospective multicenter study (six European centers). The primary end- points were technical success, incidence of major adverse events (MAEs), access failure, deployment failure, de- ployment accuracy, and rate of intraoperative endoleaks (ELs). Results: One hundred-sixteen patients with varying thoracic aortic diseases were included. Eighteen patients (15.5%) were treated for an off-label condition. The technical success rate was 100%, without any access or de- ployment failures. The proximal and distal deployment accuracy rates were 99.1% and 97.4%, respectively. There were no intraoperative MAEs, including death. Two (1.7%) type Ib ELs were detected at the first postoper- ative CTA, all of which were in off-label procedures and related to the short length of the sealing neck. No type III ELs were detected. The median hospitalization time was 8 days (IQR 4–12), including a median intensive care unit stay of 1 day (IQR 1–2). The in-hospital mortality rate was 4.3%. At a median follow-up time of 98 days (IQR 39–187), there were no aortic-related mortalities or new onset of endoleaks. Conclusion: Our initial experience with the Valiant NavionTM endograft in a wide variety of aortic diseases showed safe early outcomes, especially for on-label procedures.

Valvidia, A. R., Kratimenos, T., Ferraresi, M., Sica, S., Lovato, L., Accarino, G., Pagliaricco, G., Tshomba, Y., Tinelli, G., Gandarias, C., Pacini, D., Tomais, D., Gatta, E., Schiavon, S., Accarino, G., Minelli, F., De Nigris, F., (Abstract) A multicenter “real-world” study of the valiant NAVION stent graft, <<INTERNATIONAL JOURNAL OF CARDIOLOGY>>, 2020; (N/A): N/A-N/A. [doi:10.1016/j.ijcard.2020.10.064] [http://hdl.handle.net/10807/163018]

A multicenter “real-world” study of the valiant NAVION stent graft

Tshomba, Yamume;Tinelli, Giovanni
Ultimo
;
Minelli, Fabrizio;De Nigris, Francesca
2020

Abstract

Background: The aim of the present study was to evaluate early results of thoracic endovascular aortic repair (TEVAR) using the Valiant NavionTM stent graft in a “real-world” scenario. Methods: All patients who underwent TEVAR with the Valiant NavionTM endograft between November 2018 and November 2019 were included in this retrospective multicenter study (six European centers). The primary end- points were technical success, incidence of major adverse events (MAEs), access failure, deployment failure, de- ployment accuracy, and rate of intraoperative endoleaks (ELs). Results: One hundred-sixteen patients with varying thoracic aortic diseases were included. Eighteen patients (15.5%) were treated for an off-label condition. The technical success rate was 100%, without any access or de- ployment failures. The proximal and distal deployment accuracy rates were 99.1% and 97.4%, respectively. There were no intraoperative MAEs, including death. Two (1.7%) type Ib ELs were detected at the first postoper- ative CTA, all of which were in off-label procedures and related to the short length of the sealing neck. No type III ELs were detected. The median hospitalization time was 8 days (IQR 4–12), including a median intensive care unit stay of 1 day (IQR 1–2). The in-hospital mortality rate was 4.3%. At a median follow-up time of 98 days (IQR 39–187), there were no aortic-related mortalities or new onset of endoleaks. Conclusion: Our initial experience with the Valiant NavionTM endograft in a wide variety of aortic diseases showed safe early outcomes, especially for on-label procedures.
Inglese
Valvidia, A. R., Kratimenos, T., Ferraresi, M., Sica, S., Lovato, L., Accarino, G., Pagliaricco, G., Tshomba, Y., Tinelli, G., Gandarias, C., Pacini, D., Tomais, D., Gatta, E., Schiavon, S., Accarino, G., Minelli, F., De Nigris, F., (Abstract) A multicenter “real-world” study of the valiant NAVION stent graft, <<INTERNATIONAL JOURNAL OF CARDIOLOGY>>, 2020; (N/A): N/A-N/A. [doi:10.1016/j.ijcard.2020.10.064] [http://hdl.handle.net/10807/163018]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/163018
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact